Protect the kidneys during chemotherapy. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy16

Kidney Kidney Tubules Kidney Cortex Kidney Glomerulus Kidney Tubules, Proximal Kidney Medulla Kidney Tubules, Collecting Cell Line, Tumor Kidney Tubules, Distal Nephrons Ureter Liver Cell Line Bone Marrow Tumor Cells, Cultured Hepatic Artery

Organisms3

Dogs Mice, Nude Rats, Sprague-Dawley

Diseases80

Kidney Diseases Breast Neoplasms Acute Kidney Injury Lung Neoplasms Kidney Failure, Chronic Kidney Neoplasms Neoplasm Recurrence, Local Polycystic Kidney Diseases Neoplasms Carcinoma, Non-Small-Cell Lung Neoplasm Metastasis Ovarian Neoplasms Testicular Neoplasms Adenocarcinoma Neutropenia Vomiting Lymphoma, Non-Hodgkin Nausea Hodgkin Disease Kidney Calculi Colorectal Neoplasms Polycystic Kidney, Autosomal Dominant Disease Progression Neoplasms, Germ Cell and Embryonal Brain Neoplasms Bone Neoplasms Osteosarcoma Leukopenia Liver Neoplasms Recurrence Peritoneal Neoplasms Lymphatic Metastasis Stomach Neoplasms Germinoma Carcinoma Carcinoma, Squamous Cell Precursor Cell Lymphoblastic Leukemia-Lymphoma Lymphoma Leukemia, Myeloid, Acute Kidney Diseases, Cystic Thrombocytopenia Sarcoma Head and Neck Neoplasms Neoplasm, Residual Retroperitoneal Neoplasms Lymphoma, Large B-Cell, Diffuse Pancreatic Neoplasms Seminoma Colonic Neoplasms Mediastinal Neoplasms Stomatitis Neoplasms, Second Primary Central Nervous System Neoplasms Hematologic Diseases Anemia Leukemia, Myeloid Multiple Myeloma Esophageal Neoplasms Kidney Tubular Necrosis, Acute Disease Models, Animal Neoplasms, Glandular and Epithelial Dysgerminoma Rectal Neoplasms Urinary Bladder Neoplasms Nasopharyngeal Neoplasms Mesothelioma Soft Tissue Neoplasms Acute Disease Mucositis Leukemia Medulloblastoma Wilms Tumor Pleural Neoplasms Retinal Neoplasms Lymphoma, B-Cell Proteinuria Fatigue Abdominal Neoplasms Vomiting, Anticipatory Multicystic Dysplastic Kidney

Chemicals and Drugs67

Antineoplastic Agents Cisplatin Cyclophosphamide Doxorubicin Etoposide Methotrexate Carboplatin Paclitaxel Vinblastine Taxoids Ifosfamide Bleomycin Deoxycytidine Organoplatinum Compounds Antimetabolites, Antineoplastic Anthracyclines Antineoplastic Agents, Alkylating Cytarabine Antineoplastic Agents, Phytogenic Antibiotics, Antineoplastic Dacarbazine Carmustine Granulocyte Colony-Stimulating Factor Lomustine Camptothecin Platinum Compounds Melphalan Mitomycin Tumor Markers, Biological Antiemetics Thiotepa Mitoxantrone Antibodies, Monoclonal, Humanized Tegafur Antibodies, Monoclonal Daunorubicin Bridged Compounds Vindesine Platinum Creatinine RNA, Messenger Oxonic Acid Antibodies, Monoclonal, Murine-Derived Prednisolone Receptor, erbB-2 Recombinant Proteins Mesna P-Glycoprotein Receptors, Estrogen Dexamethasone Nimustine Granisetron Tamoxifen Mitomycins Floxuridine Radiopharmaceuticals Asparaginase Angiogenesis Inhibitors Chlorambucil Ondansetron Antineoplastic Agents, Hormonal Biological Markers Thioguanine Biomarkers, Pharmacological 6-Mercaptopurine Quinazolines Immunosuppressive Agents

Analytical, Diagnostic and Therapeutic Techniques and Equipment69

Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Combined Modality Therapy Kidney Transplantation Treatment Outcome Neoadjuvant Therapy Disease-Free Survival Survival Analysis Neoplasm Staging Prognosis Survival Rate Drug Administration Schedule Induction Chemotherapy Follow-Up Studies Kidney Function Tests Chemotherapy, Cancer, Regional Perfusion Salvage Therapy Prospective Studies Transplantation, Autologous Radiotherapy, Adjuvant Radiotherapy Kaplan-Meier Estimate Clinical Trials as Topic Infusions, Intra-Arterial Infusions, Intravenous Hematopoietic Stem Cell Transplantation Drug Therapy Immunohistochemistry Glomerular Filtration Rate Palliative Care Radiotherapy Dosage Randomized Controlled Trials as Topic Risk Factors Multivariate Analysis Proportional Hazards Models Chemoradiotherapy Hyperthermia, Induced Nephrectomy Maintenance Chemotherapy Feasibility Studies Predictive Value of Tests Cranial Irradiation Clinical Trials, Phase III as Topic Fatal Outcome Actuarial Analysis Tomography, X-Ray Computed Bone Marrow Transplantation Pilot Projects Cohort Studies Administration, Oral Mastectomy Risk Assessment Treatment Failure Consolidation Chemotherapy Drug Evaluation Disease Models, Animal Clinical Trials, Phase II as Topic Random Allocation Biopsy Hematopoietic Stem Cell Mobilization Antineoplastic Protocols Infusions, Parenteral Xenograft Model Antitumor Assays Drug Screening Assays, Antitumor Transplantation, Homologous Reverse Transcriptase Polymerase Chain Reaction Preoperative Care Positron-Emission Tomography Immunotherapy

Phenomena and Processes13

Drug Resistance, Neoplasm Time Factors Dose-Response Relationship, Drug Glomerular Filtration Rate Kidney Concentrating Ability Apoptosis Tissue Distribution Graft Survival Gene Expression Regulation, Neoplastic Drug Resistance, Multiple Drug Synergism Cell Survival Graft Rejection

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

Quality of Life

Humanities1

Quality of Life

Information Science3

Survival Rate Fatal Outcome Molecular Sequence Data

Named Groups1

Health Care27

Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Follow-Up Studies Prospective Studies Kaplan-Meier Estimate Clinical Trials as Topic Palliative Care Randomized Controlled Trials as Topic Risk Factors Multivariate Analysis Proportional Hazards Models Feasibility Studies Predictive Value of Tests Clinical Trials, Phase III as Topic Fatal Outcome Actuarial Analysis Age Factors Pilot Projects Cohort Studies Risk Assessment Treatment Failure Clinical Trials, Phase II as Topic Random Allocation Antineoplastic Protocols Preoperative Care

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Health Care

Antineoplastic Combined Chemotherapy Protocols Kidney Chemotherapy, Adjuvant Kidney Diseases Combined Modality Therapy Antineoplastic Agents Cisplatin Kidney Transplantation Treatment Outcome Cyclophosphamide Doxorubicin Neoadjuvant Therapy Kidney Tubules Disease-Free Survival Breast Neoplasms Etoposide Survival Analysis Kidney Cortex Neoplasm Staging Prognosis Survival Rate Acute Kidney Injury Drug Administration Schedule Lung Neoplasms Methotrexate Kidney Failure, Chronic Carboplatin Paclitaxel Kidney Neoplasms Vinblastine Induction Chemotherapy Neoplasm Recurrence, Local Taxoids Ifosfamide Drug Resistance, Neoplasm Time Factors Polycystic Kidney Diseases Neoplasms Kidney Glomerulus Bleomycin Follow-Up Studies Deoxycytidine Organoplatinum Compounds Antimetabolites, Antineoplastic Kidney Function Tests Kidney Tubules, Proximal Kidney Medulla Anthracyclines Antineoplastic Agents, Alkylating Chemotherapy, Cancer, Regional Perfusion Cytarabine Salvage Therapy Carcinoma, Non-Small-Cell Lung Neoplasm Metastasis Ovarian Neoplasms Prospective Studies Testicular Neoplasms Transplantation, Autologous Adenocarcinoma Neutropenia Vomiting Lymphoma, Non-Hodgkin Nausea Antineoplastic Agents, Phytogenic Radiotherapy, Adjuvant Hodgkin Disease Kidney Calculi Radiotherapy Colorectal Neoplasms Kaplan-Meier Estimate Dose-Response Relationship, Drug Antibiotics, Antineoplastic Clinical Trials as Topic Kidney Tubules, Collecting Dacarbazine Polycystic Kidney, Autosomal Dominant Disease Progression Neoplasms, Germ Cell and Embryonal Carmustine Granulocyte Colony-Stimulating Factor Lomustine Camptothecin Brain Neoplasms Bone Neoplasms Platinum Compounds Infusions, Intra-Arterial Osteosarcoma Leukopenia Melphalan Liver Neoplasms Mitomycin Infusions, Intravenous Tumor Markers, Biological Antiemetics Recurrence Hematopoietic Stem Cell Transplantation Thiotepa Peritoneal Neoplasms Drug Therapy Immunohistochemistry

No FAQ available that match "protect the kidneys during chemotherapy"